European Commission approves Roche's MabThera (rituximab) for a rare autoimmune disease

World News: . []

F Hoffmann-La Roche Ltd European Commission approves LINK  MabThera rituximab for a rare autoimmune
disease
Processed and transmitted by West CorporationThe issuer is LINK  responsible for the content of this announcement r /> ...

More news and information about F. Hoffmann-La Roche Ltd

Published By:

Thomson Reuters: 06:00 GMT Friday 15th March 2019

Published: .

Search for other references to "european" on SPi News


Share

Previous StoryNext Story

SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2019. [Admin Only]
 
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 07519380.
 
Privacy Policy | Terms and Conditions | Contact Us